Exclusive

Publication

Byline

Location

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, Jan. 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on Jan. 21 b... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM; NOTICE OF MEETING

WASHINGTON, Jan. 21 -- National Institutes of Health has issued a notice called: National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting. The notice was published in the Federal Registe... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; NOTICE OF MEETINGS

WASHINGTON, Jan. 21 -- National Institutes of Health has issued a notice called: National Institute of Allergy and Infectious Diseases; Notice of Meetings. The notice was published in the Federal Reg... Read More


DEPARTMENT OF HEALTH AND HUMAN SERVICES ISSUES NOTICE: HEALTH INFORMATION TECHNOLOGY ADVISORY COMMITTEE SCHEDULE OF MEETINGS

WASHINGTON, Jan. 21 -- Department Of Health And Human Services has issued a notice called: Health Information Technology Advisory Committee Schedule of Meetings. The notice was published in the Feder... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AUTHORIZATION OF EMERGENCY USE OF CERTAIN MEDICAL DEVICES DURING COVID-19; AVAILABILITY

WASHINGTON, Jan. 21 -- Food and Drug Administration has issued a notice called: Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability. The notice was published in th... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: M4Q(R2) THE COMMON TECHNICAL DOCUMENT FOR THE REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE: QUALITY; INTERNATIONAL COUNCIL FOR HARMONISATION; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, Jan. 21 -- Food and Drug Administration has issued a notice called: M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality; International Coun... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: MINIMAL RESIDUAL DISEASE AND COMPLETE RESPONSE IN MULTIPLE MYELOMA: USE AS ENDPOINTS TO SUPPORT ACCELERATED APPROVAL; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, Jan. 21 -- Food and Drug Administration has issued a notice called: Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints To Support Accelerated Approval; Dr... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: NOTICE OF APPROVAL OF PRODUCT UNDER VOUCHER: RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER; RHAPSIDO (REMIBRUTINIB)

WASHINGTON, Jan. 21 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; RHAPSIDO (Remibrutinib). T... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ISSUANCE OF PRIORITY REVIEW VOUCHER; RARE PEDIATRIC DISEASE PRODUCT; KYGEVVI (DOXECITINE AND DOXRIBTIMINE)

WASHINGTON, Jan. 21 -- Food and Drug Administration has issued a notice called: Issuance of Priority Review Voucher; Rare Pediatric Disease Product; KYGEVVI (Doxecitine and Doxribtimine). The notice ... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES: SUBMISSION FOR OMB REVIEW; COMMENT REQUEST

WASHINGTON, Jan. 21 -- Centers for Medicare & Medicaid Services has issued a notice called: Agency Information Collection Activities: Submission for OMB Review; Comment Request. The notice was publis... Read More